Mesoblast
MESO
#4331
Rank
ยฃ1.81 B
Marketcap
ยฃ14.10
Share price
3.59%
Change (1 day)
65.79%
Change (1 year)

Revenue for Mesoblast (MESO)

Revenue in 2022: ยฃ6.45 Million

According to Mesoblast 's latest financial reports the company's current revenue (TTM ) is ยฃ5.75 Million. In 2022 the company made a revenue of ยฃ6.45 Million a decrease over the revenue in the year 2021 that were of ยฃ7.32 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Mesoblast from 2015 to 2022

Annual revenue

Year Revenue Change
2022ยฃ6.45 M-11.82%
2021ยฃ7.32 M-38.81%
2020ยฃ11.96 M-25.73%
2019ยฃ16.11 M28.75%
2018ยฃ12.51 M6.01%
2017ยฃ11.8 M-54.26%
2016ยฃ25.81 M59.83%
2015ยฃ16.14 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
NRC Health
NRC
ยฃ0.10 B 1,717.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
N/AN/A Bahamas